Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis.

ABSTRACT:

Objectives

Patients with inflammatory bowel disease (IBD) may experience comorbidities involving metabolic syndrome (MetS). However, this association remains controversial. Our objective was to estimate the prevalence of MetS in patients with IBD and assess whether MetS is more strongly associated with ulcerative colitis (UC) or Crohn's disease (CD).

Design

Systematic review and meta-analysis.

Data sources

PubMed, Cochrane Library, Web of Science, EMBASE and MEDLINE were searched from their inception to July 2022.

Eligibility criteria

Observational studies reporting data regarding the rate of comorbid MetS among patients with IBD and published in English.

Data extraction and synthesis

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses

SUBMITTER: Shen Z 

PROVIDER: S-EPMC10921521 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature